A5027130004- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Management and Education
- Diabetes and associated disorders
- Global Public Health Policies and Epidemiology
- Chronic Disease Management Strategies
- Diabetes Treatment and Management
- Liver Disease Diagnosis and Treatment
- Metabolism, Diabetes, and Cancer
- Retinal Diseases and Treatments
- Gestational Diabetes Research and Management
- Tuberculosis Research and Epidemiology
- Chronic Kidney Disease and Diabetes
- Pneumocystis jirovecii pneumonia detection and treatment
- Health Promotion and Cardiovascular Prevention
- Cardiovascular Health and Risk Factors
- Diet, Metabolism, and Disease
- Pregnancy and preeclampsia studies
- Bariatric Surgery and Outcomes
- Retinal Imaging and Analysis
- Diagnosis and treatment of tuberculosis
- Sperm and Testicular Function
- Optimism, Hope, and Well-being
- Pancreatic function and diabetes
- Diet and metabolism studies
World Health Organization
2010-2021
World Health Organization - Pakistan
2005-2020
Aarhus University
2012
MRC Epidemiology Unit
2012
Addenbrooke's Hospital
2012
University College London
1999
Semmelweis University
1999
Centre Hospitalier de Luxembourg
1999
University of Zagreb
1993
OBJECTIVE—The goal of this study was to estimate the prevalence diabetes and number people all ages with for years 2000 2030. RESEARCH DESIGN AND METHODS—Data on by age sex from a limited countries were extrapolated 191 World Health Organization member states applied United Nations’ population estimates Urban rural populations considered separately developing countries. RESULTS—The age-groups worldwide estimated be 2.8% in 4.4% The total is projected rise 171 million 366 higher men than...
We read the article by McCarter et al. (1) with interest. Technically, all nonanalytical variation, irrespective of its source, is biological variation. Thus, mean blood glucose (MBG)-associated changes are included in It must also be stressed that population regression equations have confidence limits need to taken into account when comparing values from individuals study mean. However, such …
OBJECTIVE—To estimate the global number of excess deaths due to diabetes in year 2000. RESEARCH DESIGN AND METHODS—We used a computerized generic formal disease model (DisMod II), by World Health Organization assess burden through modeling relationships between incidence, prevalence, and disease-specific mortality. Baseline input data included population structure, age- sex-specific estimates available published relative risk death for people with compared without diabetes. The results were...
The first WHO Global Report on Diabetes was launched World Health Day 7 th April 2016 which dedicated to (1). has been described in ancient scripts and recognized as a serious illness, but it does not appear have frequently encountered by physicians or healers. It is the past few decades that human health development increasingly affected rising numbers of people with this condition. Diabetes, together cardiovascular disease, cancer chronic respiratory disease targeted Political Declaration...
Abstract Background Tuberculosis (TB) remains a major cause of mortality in developing countries, and these countries diabetes prevalence is increasing rapidly. Diabetes increases the risk TB. Our aim was to assess potential impact as factor for incident pulmonary tuberculosis, using India an example. Methods We constructed epidemiological model data on tuberculosis incidence, prevalence, population structure, relative associated with diabetes. evaluated contribution made by both difference...
Data on type 1 diabetes incidence and prevalence are limited, particularly for adults. This study aims to estimate global numbers of incident prevalent cases in 2017 all age groups, by country areas defined income region.Incidence rates children (available from 94 countries) the IDF Atlas were used extrapolated countries without data. Age-specific adults (only known across full range fewer than ten obtained applying scaling ratios each adult group relative rate children. applied population...
The steadily growing epidemic of diabetes mellitus poses a threat for global tuberculosis (TB) control. Previous studies have identified an important association between and TB. However, these limitations: very few were carried out in low-income countries, with none Africa, raising uncertainty about the strength mellitus-TB settings, many critical questions remain unanswered. An expert meeting was held November 2009 to discuss where there sufficient evidence make firm recommendations joint...
The World Health Organization developed these guidelines to provide guidance on selection of medicines for treatment intensification in type 2 diabetes and use insulin (human or analogue) 1 diabetes. target audience includes clinicians, policymakers, national program managers, medicine procurement officers. population is adults with low-resource settings low- high-income countries. also apply disadvantaged populations countries.The recommendations were formulated by a 12-member guideline...
A major objective of the IFCC Task Force on Implementation HbA1c Standardization is to develop a model define quality targets for glycated hemoglobin (Hb A1c).
Background Diabetes prevalence and body mass index reflect the nutritional profile of populations but have opposing effects on tuberculosis risk. Interactions between diabetes BMI could help or hinder TB control in growing, aging, urbanizing populations. Methods Findings We compiled data describing temporal changes BMI, population age structure rural urban areas for men women countries with high (India) low (Rep. Korea) burdens. Using published risks associated these factors, we calculated...